About this journal

Biomarkers in Medicine  is a MEDLINE-indexed, peer-reviewed journal delivering vital research, commentary and analysis to the multidisciplinary biomarker research community.

Biomarker research drives the development of new predictive, diagnostic and prognostic techniques, and also plays an important role in the discovery and development of new drugs. Biomarkers in Medicine advances understanding in the potential and actual applications of this research, translating knowledge into the clinic and increasing the effectiveness of medical practice.

High-quality, methodologically sound papers are considered in the following areas, with manuscripts presenting multicenter human studies and clinical trials being given particular priority:

• Predictive, diagnostic and prognostic biomarkers
• Biomarkers in drug discovery and development, including pharmacokinetic/pharmacodynamic modeling and simulation
• Biomarkers for clinical safety assessment and predicting adverse effects
• Biomarkers in treatment decision making and monitoring
• Optimum biomarker selection, validation and application
• Bioanalytical method development and validation
• Impact of biomarkers on medicine, including regulatory and ethical issues

The journal welcomes unsolicited article proposals, including for the submission of original research, narrative and systematic reviews, and opinion pieces. The journal offers rapid and open access publishing options.

Senior Editors

Terzic A, Mayo Clinic, MN, USA
Waldman SA, Thomas Jefferson University, PA, USA

International Editorial Advisory Board

Ablin RJ, University of Arizona, AZ, USA
Bartunek J, OLV Ziekenhuis, Belgium
Bonventre JV, Harvard Medical School, MA, USA
Buhimschi I, Yale University School of Medicine, CT, USA
Bustin S, Anglia Ruskin University, UK
Camphausen K, National Cancer Institute, MD, USA
Chervoneva I, Thomas Jefferson Universiy, PA, USA
Ebert M, University of Mannheim, Germany
von Eggeling F, Friedrich-Schiller-University Jena, Germany
Feldstein A, University of California, San Diego, CA, USA
Fernandez-Aviles F, University Hospital Gregorio Marañon, Spain
Fritsche H, MD Anderson Cancer Center, TX, USA
Gardner R, Golden Jubilee National Hospital, UK
Gøtze JP, University of Copenhagen, Denmark
Gries JM, Covance, NJ, USA
Hammarström S, Umea University, Sweden
Haughey NJ, Johns Hopkins University School of Medicine, MD, USA
Hong H, US FDA, AR, USA
Hoon DSB, John Wayne Cancer Institute, CA, USA
Hoque MO, Johns Hopkins University School of Medicine, MD, USA
Huang S-M, US FDA, USA
Hyslop T, Thomas Jefferson University, PN, USA
Jaffe AS, Mayo Clinic, MN, USA
Li M, University of Texas Medical School at Houston, TX, USA
Libri V, Imperial College London, UK
Licinio J, University of Miami, USA
Lively T, National Cancer Institute, MD, USA
Liotta LA, George Mason University, VA, USA
Maimonis P, MA, USA
Mallal S, Murdoch University, Australia
Maniscalco M, ICS Maugeri of Telese, Italy
McLeod HL, University of North Carolina, NC, USA
Menown IB, Craigavon Area Hospital, UK
Nicolini A, University of Pisa, Italy
Petricoin EF, George Mason University, VA, USA
Ratain MJ, University of Chicago, IL, USA
Relkin NR, The Weill Cornell Medical College, NY, USA
Ridker PM, Harvard Medical School, MA, USA
Ross JS, Albany Medical College, NY, USA
Roukos D, Ioannina University, Greece
Ryder S, Astellas Pharma Global Development, IL, USA
Sadhukhan P, Johns Hopkins University School of Medicine, MD, USA
Sauter ER, University of North Dakota, ND, USA
Schernthaner G, Rudolfstiftung Hospital Vienna, Austria
Scherzer CR, Harvard Medical School, MA, USA
Sikora K, Hammersmith Hospital, UK
Srivastava S, National Cancer Institute, MD, USA
Tammen H, Digilab BioVisioN, Germany
Temple R, FDA, MD, USA
Thongboonkerd V, Siriraj Hospital, Mahidol University, Thailand
Thurin M, National Cancer Institute, MD, USA
Turck C, Max Planck Institute of Psychiatry, Germany
Wang K, University of Florida, FL, USA
Wilson I, Imperial College London, UK
Zetterberg H, Sahlgrenska Academy, Sweden